Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00EPT
|
|||
Former ID |
DNCL002729
|
|||
Drug Name |
E7850
|
|||
Synonyms |
Irofulven
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 2 | [1], [2] | |
Company |
Eisai
|
|||
Structure |
Download2D MOL |
|||
Formula |
C15H18O3
|
|||
Canonical SMILES |
CC1=C(C2=C(C3(CC3)C(C(=O)C2=C1)(C)O)C)CO
|
|||
InChI |
1S/C15H18O3/c1-8-6-10-12(11(8)7-16)9(2)15(4-5-15)14(3,18)13(10)17/h6,16,18H,4-5,7H2,1-3H3/t14-/m0/s1
|
|||
InChIKey |
NICJCIQSJJKZAH-AWEZNQCLSA-N
|
|||
CAS Number |
CAS 158440-71-2
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:135002
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Serine/threonine-protein kinase Chk2 (RAD53) | Target Info | Modulator | [3] |
KEGG Pathway | Cell cycle | |||
p53 signaling pathway | ||||
HTLV-I infection | ||||
Pathway Interaction Database | ATM pathway | |||
FOXM1 transcription factor network | ||||
p53 pathway | ||||
PLK3 signaling events | ||||
Reactome | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | |||
G2/M DNA damage checkpoint | ||||
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | ||||
WikiPathways | DNA Damage Response | |||
ATM Signaling Pathway | ||||
Integrated Pancreatic Cancer Pathway | ||||
Prostate Cancer | ||||
Integrated Breast Cancer Pathway | ||||
Integrated Cancer pathway | ||||
Cell Cycle | ||||
miRNA Regulation of DNA Damage Response |
References | Top | |||
---|---|---|---|---|
REF 1 | Irofulven induces replication-dependent CHK2 activation related to p53 status. Biochem Pharmacol. 2007 Feb 15;73(4):469-80. | |||
REF 2 | ATM-dependent CHK2 activation induced by anticancer agent, irofulven. J Biol Chem. 2004 Sep 17;279(38):39584-92. | |||
REF 3 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1988). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.